Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles.
about
Functionally-interdependent shape-switching nanoparticles with controllable properties.Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles.Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.Construction of RNA-Quantum Dot Chimera for Nanoscale Resistive Biomemory Application.RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applicationsSystemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.Controllable self-assembly of RNA dendrimersAdvancement of the Emerging Field of RNA Nanotechnology.Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.Controllable Self-Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting.Fabrication of RNA 3D Nanoprisms for Loading and Protection of Small RNAs and Model Drugs.Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties.Programmable RNA microstructures for coordinated delivery of siRNAs.RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.Computational Prediction of the Immunomodulatory Potential of RNA Sequences.Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles.Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.Programmable Nucleic Acid Based Polygons with Controlled Neuroimmunomodulatory Properties for Predictive QSAR Modeling.Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.RNA nanoparticle distribution and clearance in the eye after subconjunctival injection with and without thermosensitive hydrogels.RNA-based micelles: A novel platform for chemotherapeutic drug loading and delivery.The Effect of Size and Shape of RNA Nanoparticles on Biodistribution.RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications.Evaluation of Thermal Stability of RNA Nanoparticles by Temperature Gradient Gel Electrophoresis (TGGE) in Native Condition.Hydrophobic Effect from Conjugated Chemicals or Drugs on In Vivo Biodistribution of RNA Nanoparticles.Engineering nanoparticles to overcome barriers to immunotherapy.Cotranscriptionally Folded RNA Nanostructures Pave the Way to Intracellular NanofabricationRecent Progress on Nanostructures for Drug Delivery Applications
P2860
Q33558416-FBC8892D-C76E-4FAD-8333-7AE7104E24B7Q35027155-53C8C302-AA43-47F3-ADDB-913B2F282D00Q35813076-19C854B5-2BE3-430D-9FCC-D0608A0F69B8Q35866025-2A569B47-76B5-4406-8962-BDBB2BEB42C5Q36020835-7D2B1261-3B51-4827-9102-3740795E766CQ36185327-6EB5700A-564E-44B6-8993-4779A5346128Q36269694-562F7756-1E49-41E1-B1BB-338E1D739F3EQ36273286-C4AA71D6-2EE1-45A5-A3E7-2712F4CDF17EQ36449335-911D23CC-B7F0-43B9-9C24-E1F73956EC00Q36490744-24563C7B-7409-462B-A789-F5C4BFE5E360Q38774730-E521473F-7A6B-4A47-8B6C-515CB6A04119Q38812570-FFE3B2C8-BB57-4551-B814-20915584810EQ39065708-9D5BB97A-7BFF-4738-9110-AAA6E4DD0597Q40564594-60D45835-78C8-4980-8546-0CCC5007817AQ41432210-809A3696-2637-4DBB-B54D-2342A7682E60Q41600364-760159C8-C6A5-4B63-916C-91878E1D30CBQ41885592-6ADB5FE6-CF5B-4279-9FEA-E8E4CD4A5AC3Q42333676-379E442F-94C6-4CC1-AE51-219595958440Q45863841-CD41926D-6E9F-45C9-B5CD-963C130357D7Q45946589-93FB81CD-8AFA-4DF3-B356-0D4AF97C5900Q47097375-1901714D-C9E3-4ACB-88B8-E6305999D767Q47199019-0693D370-9A67-4049-9A07-810094516012Q47663129-F7584B3C-260D-4F78-827C-01EDAF4D26F1Q49529515-C0EC7B35-69AD-4036-8EC0-BBF9E697FA89Q49693374-97A8F864-39B4-4FCC-A95A-915839CC53F7Q49904261-266E6106-0ED0-418E-BA89-7E5367757ADDQ50061940-BE6312EC-7EE3-4F48-B2D9-B117BCCFC892Q50144632-6906334C-148F-49E4-A428-AAE85A8FA247Q52568522-1BEC4E7E-3D16-42F1-ACE0-53E3D757AB46Q52768074-430F37D4-436D-49FE-81C0-DCB86B3192CEQ54991276-C1B2726C-48D9-4679-A5C8-A548A8807864Q57156492-0E2A5C73-BD66-4FB8-9E32-E7678FCEF39DQ59128282-CB0E05BF-BEDC-40DA-8E0F-D08C1F2D1BBE
P2860
Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@ast
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@en
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@nl
type
label
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@ast
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@en
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@nl
prefLabel
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@ast
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@en
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@nl
P2093
P2860
P356
P1476
Enhancing immunomodulation on ...... are and pentagon nanovehicles.
@en
P2093
Daniel L Jasinski
Emil F Khisamutdinov
Peixuan Guo
P2860
P304
9996-10004
P356
10.1093/NAR/GKU516
P407
P577
2014-08-04T00:00:00Z